Dr. Mark Reed, M.D

NPI: 1992768261
Total Payments
$4,197
2024 Payments
$840.91
Companies
26
Transactions
239
Medicare Patients
3,561
Medicare Billing
$287,073

Payment Breakdown by Category

Food & Beverage$4,128 (98.3%)
Education$69.47 (1.7%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,128 235 98.3%
Education $69.47 4 1.7%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $672.74 38 $0 (2024)
AstraZeneca Pharmaceuticals LP $610.32 27 $0 (2021)
Boehringer Ingelheim Pharmaceuticals, Inc. $494.07 30 $0 (2024)
Lilly USA, LLC $395.89 27 $0 (2024)
SANOFI-AVENTIS U.S. LLC $279.44 15 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $257.24 16 $0 (2022)
Janssen Pharmaceuticals, Inc $240.31 12 $0 (2020)
ABBVIE INC. $220.01 11 $0 (2024)
PFIZER INC. $189.28 11 $0 (2024)
Phathom Pharmaceuticals, Inc. $158.52 8 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $840.91 47 Novo Nordisk Inc ($354.64)
2023 $636.11 35 Novo Nordisk Inc ($283.70)
2022 $435.81 27 SANOFI-AVENTIS U.S. LLC ($101.90)
2021 $610.40 41 Takeda Pharmaceuticals U.S.A., Inc. ($137.65)
2020 $953.00 53 AstraZeneca Pharmaceuticals LP ($252.86)
2019 $323.74 15 AstraZeneca Pharmaceuticals LP ($135.48)
2018 $307.95 15 AstraZeneca Pharmaceuticals LP ($206.93)
2017 $89.39 6 Supernus Pharmaceuticals, Inc. ($41.10)

All Payment Transactions

239 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/13/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $17.82 General
Category: Diabetes
12/04/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $6.36 General
Category: DIABETES
12/03/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $7.53 General
Category: Diabetes
11/22/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $24.86 General
Category: Diabetes
11/19/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $22.00 General
Category: GASTROENTEROLOGY
11/18/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $7.40 General
Category: DIABETES
11/08/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $17.31 General
Category: Diabetes
11/06/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $18.48 General
Category: PAIN
10/31/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $17.66 General
Category: Obesity
10/23/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $20.98 General
Category: DIABETES
10/16/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $20.75 General
Category: Diabetes
09/13/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $18.75 General
Category: Obesity
09/09/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $21.11 General
Category: Diabetes
09/04/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $15.11 General
Category: Inflammation
09/03/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $22.89 General
Category: DIABETES
08/28/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.47 General
Category: Diabetes
08/16/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $16.59 General
Category: GASTROENTEROLOGY
08/15/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $20.03 General
Category: Obesity
08/12/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $16.38 General
Category: Diabetes
07/31/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $23.75 General
Category: GASTROENTEROLOGY
07/30/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $34.39 General
Category: NEUROSCIENCE
07/17/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $13.44 General
Category: Diabetes
07/15/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $25.17 General
Category: DIABETES
06/25/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $17.01 General
Category: Obesity
06/11/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $19.87 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 733 1,096 $104,028 $64,355
2022 12 927 1,292 $123,707 $68,009
2021 13 991 1,474 $136,724 $86,700
2020 12 910 1,405 $118,735 $68,009
Total Patients
3,561
Total Services
5,267
Medicare Billing
$287,073
Procedure Codes
45

All Medicare Procedures & Services

45 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 218 218 $28,340 $26,031 91.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 207 347 $43,375 $25,241 58.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 134 170 $20,400 $8,259 40.5%
83036 Hemoglobin a1c level Office 2023 110 265 $6,625 $2,454 37.0%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 11 11 $2,123 $1,686 79.4%
20610 Aspiration and/or injection of fluid from large joint Office 2023 14 16 $1,440 $486.48 33.8%
J1030 Injection, methylprednisolone acetate, 40 mg Office 2023 14 34 $850.00 $120.37 14.2%
81003 Automated urinalysis test Office 2023 25 35 $875.00 $77.00 8.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 232 232 $30,160 $26,538 88.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 219 324 $40,500 $21,252 52.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 208 278 $33,360 $12,094 36.3%
83036 Hemoglobin a1c level Office 2022 130 267 $6,675 $2,498 37.4%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 14 14 $2,702 $2,054 76.0%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 13 13 $2,080 $1,905 91.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 13 13 $1,625 $788.05 48.5%
20610 Aspiration and/or injection of fluid from large joint Office 2022 11 12 $1,080 $445.15 41.2%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 32 34 $2,550 $206.61 8.1%
96372 Injection of drug or substance under skin or into muscle Office 2022 12 14 $700.00 $118.24 16.9%
81003 Automated urinalysis test Office 2022 32 43 $1,075 $95.53 8.9%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2022 11 48 $1,200 $14.36 1.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 249 249 $32,370 $31,055 95.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 267 413 $44,165 $21,472 48.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 184 279 $34,875 $21,090 60.5%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2021 20 20 $3,200 $3,181 99.4%
99496 Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge Office 2021 15 18 $3,960 $3,168 80.0%

About Dr. Mark Reed, M.D

Dr. Mark Reed, M.D is a Nurse Practitioner healthcare provider based in Pikeville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992768261.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Reed, M.D has received a total of $4,197 in payments from pharmaceutical and medical device companies, with $840.91 received in 2024. These payments were reported across 239 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,128).

As a Medicare-enrolled provider, Reed has provided services to 3,561 Medicare beneficiaries, totaling 5,267 services with total Medicare billing of $287,073. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Other Specialties Family, Family Medicine
  • Location Pikeville, KY
  • Active Since 04/08/2006
  • Last Updated 09/30/2021
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1992768261

Products in Payments

  • JARDIANCE (Drug) $461.79
  • FARXIGA (Drug) $422.10
  • Ozempic (Drug) $278.34
  • TRULICITY (Drug) $262.85
  • Wegovy (Drug) $258.49
  • TRINTELLIX (Drug) $241.11
  • XARELTO (Drug) $199.36
  • SOLIQUA 100/33 (Biological) $192.80
  • VOQUEZNA (Drug) $158.52
  • Rybelsus (Drug) $135.91
  • SYMBICORT (Drug) $115.57
  • TROKENDI XR (Drug) $109.70
  • UBRELVY (Drug) $103.43
  • TOUJEO (Biological) $86.64
  • QULIPTA (Drug) $80.71
  • NURTEC ODT (Drug) $80.34
  • JANUVIA (Drug) $78.46
  • ELIQUIS (Drug) $78.39
  • QUVIVIQ (Drug) $63.99
  • SPIRIVA RESPIMAT (Drug) $52.36

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Pikeville